Oncology Peer Review On-The-Go: The COVID-19 Pandemic's Impact on Cancer Screenings

Podcast

The latest episode of “Oncology Peer Review On-The-Go” examines how the coronavirus disease 2019 pandemic is impacting routine cancer screenings, and the strategies to get those appointments rescheduled.

In this week’s episode, CancerNetwork speaks with Christopher McNair, PhD, of the Sidney Kimmel Cancer Center – Jefferson Health for an in-depth discussion on how the coronavirus disease 2019 (COVID-19) pandemic has impacted cancer screenings.

Then, CancerNetwork speaks with Lisa Berry Edwards, managing director of external affairs for the PreventCancer Foundation, to talk about their “Back on the Books” initiative working to get cancer screenings and regular appointments rescheduled during the pandemic.

Don’t forget to subscribe to the “Oncology Peer Review On-The-Go” podcast on Apple Podcasts, Spotify or anywhere podcasts are available, or listen online at www.cancernetwork.com.

Newsletter

Stay up to date on recent advances in the multidisciplinary approach to cancer.

Recent Videos
4 experts in this video
2 experts in this video
2 experts in this video
4 experts in this video
Ongoing studies seek to evaluate immunotherapy in earlier lines of therapy for patients with early-stage Hodgkin lymphoma.
Strict inclusion criteria may disproportionately exclude racial minority populations from participating in breast cancer trials.
A paucity of prospective, well-vetted data to guide therapy in patients with rare lymphomas may result in a reliance on expert consensus guidelines.
Related Content